Did you know?
ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.
Free Newsletter
Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!
Free Report
For better result, minimum character length is four(4)
65th Annual Meeting Showcases Impending Drugs. More...
CBT 200 Up 3 Points Today; Down 27 Points For Week. More...
Positive Results From Initial Tests. More details...
Why Is The FDA Dragging Its Feet?. More details...
CBT 200 Gains 40 Points. More details...
CBT 200 Moves Up 37 Points. More details...
Higher Spending Does Not Mean Better Health. More details...
CBT 200 Gains 1.4%. More details...
CBT 200 Recovers From Early Drop, Gains 10 Points. More...
CBT 200 Slips 12 Points Lower. More details...
ChinaBio® News
Greg Scott Interviewed at BIO-Europe Spring
How to bring your China assets to China in 8 minutes
"Mr. Bio in China."
Mendelspod Interview
Multinational pharma held to a higher standard in China
